Description
Indicated for improving luminal diameter for the treatment of de novo or restenotic symptomatic lesions in native vascular disease of the above-the-knee femoropopliteal arteries having reference vessel diameter 4 mm to 7 mm and total lesion lengths up to 300 mm per patient.Technical Specifications
| Referência | Perfil (Fr) | Diâmetro (mm) | Comprimento (mm) | Fio Guia (pol.) | Cateter (cm) |
| ZISV6-35-125-5.0-120-PTX | 6 | 5 | 120 | 0,035 | 125 |
| ZISV6-35-125-5.0-140-PTX | 6 | 5 | 140 | 0,035 | 125 |
| ZISV6-35-125-6.0-40-PTX | 6 | 6 | 40 | 0,035 | 125 |
| ZISV6-35-125-6.0-60-PTX | 6 | 6 | 60 | 0,035 | 125 |
| ZISV6-35-125-6.0-80-PTX | 6 | 6 | 80 | 0,035 | 125 |
| ZISV6-35-125-6.0-100-PTX | 6 | 6 | 100 | 0,035 | 125 |
| ZISV6-35-125-6.0-120-PTX | 6 | 6 | 120 | 0,035 | 125 |
| ZISV6-35-125-6.0-140-PTX | 6 | 6 | 140 | 0,035 | 125 |
| ZISV6-35-125-7.0-40-PTX | 6 | 7 | 40 | 0,035 | 125 |
| ZISV6-35-125-7.0-60-PTX | 6 | 7 | 60 | 0,035 | 125 |
| ZISV6-35-125-7.0-80-PTX | 6 | 7 | 80 | 0,035 | 125 |
| ZISV6-35-125-7.0-100-PTX | 6 | 7 | 100 | 0,035 | 125 |
| ZISV6-35-125-7.0-120-PTX | 6 | 7 | 120 | 0,035 | 125 |
| ZISV6-35-125-7.0-140-PTX | 6 | 7 | 140 | 0,035 | 125 |
| ZISV6-35-125-8.0-40-PTX | 6 | 8 | 40 | 0,035 | 125 |
| ZISV6-35-125-8.0-100-PTX | 6 | 8 | 100 | 0,035 | 125 |
| ZISV6-35-125-8.0-120-PTX | 6 | 8 | 120 | 0,035 | 125 |
Partner
